B2M and Miyoshi myopathy: The International Staging System (ISS), based on serum β2-microglobulin (B2M) levels, divides MM into three stages, with the revised ISS (R-ISS) also incorporating serum lactate dehydrogenase (LDH) levels and chromosomal abnormalities [20].